How can we minimise the use of regular oral corticosteroids in asthma?

Options to achieve oral corticosteroid (OCS)-sparing have been triggering increasing interest since the 1970s because of the side-effects of OCSs, and this has now become achievable with biologics. The Société de Pneumologie de Langue Française workshop on OCSs aimed to conduct a comprehensive revie...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Arnaud Bourdin, Ian Adcock, Patrick Berger, Philippe Bonniaud, Philippe Chanson, Cécile Chenivesse, Jacques de Blic, Antoine Deschildre, Philippe Devillier, Gilles Devouassoux, Alain Didier, Gilles Garcia, Antoine Magnan, Yan Martinat, Thierry Perez, Nicolas Roche, Camille Taillé, Pierre Val, Pascal Chanez
Формат: Artigo
Язык:Inglês
Опубликовано: European Respiratory Society 2020-02-01
Серии:European Respiratory Review
Online-ссылка:http://err.ersjournals.com/content/29/155/190085.full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы